How to access the dark web safely in October 2026. Tor is the only requirement, and a VPN helps in two cases rather than all of them.

AngularJS adalah framework open-source yang dipelihara oleh Google dan komunitas pengembang. Framework ini menyederhanakan ...

Since the release of Vue 2, Vuejs has grown rapidly. It is receiving awesome reviews from the users. Vuejs was one of the ...

Ajax host FC Sion at the Johan Cruyff ArenA on Thursday evening in the second leg of the Conference League play-offs. The side of coach Míchel Sánchez defend a 2-4 lead and this time everyone in the ...

Ajax are aiming to complete their rebuild after narrowly securing European qualification last season. Under new head coach Míchel and sporting director Jordi Cruyff, the four-time European champions ...

Ajax face Shelbourne FC on Thursday evening in the third qualifying round of the Conference League. Kick-off at the sold-out Johan Cruijff ArenA is at 20:00 and the match can be followed live on ...

Sobeys on Kingston Road in Ajax will close this summer and a new grocery store within the same company will open in its place in 2027. “We are always reviewing our assets and offerings to meet the ...

Ajax Therapeutics is among about 10 publicly-announced acquisitions by Eli Lilly so far this year. (Angus Liu/Fierce Pharma) Eli Lilly’s up-to-$2.3 billion acquisition of Ajax Therapeutics is facing ...

Eli Lilly LLY-0.61%decrease; down pointing triangle continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker’s blood-cancer ...

Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...

April 27 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up ‌to $2.3 billion in cash, as the U.S. drugmaker looks to ...

Eli Lilly’s run of near-weekly acquisitions still shows no sign of letting up, with the Big Pharma now buying Ajax Therapeutics for its clinical-stage myelofibrosis therapy. At the center of the deal ...